Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05ZYA
|
|||
| Former ID |
DNC012013
|
|||
| Drug Name |
5-Bromomethyl-oxazolidin-(2Z)-ylideneamine
|
|||
| Synonyms |
5-Bromomethyl-4,5-dihydro-oxazol-2-ylamine; CHEMBL447832; 52886-60-9; 5-(bromomethyl)-4,5-dihydro-1,3-oxazol-2-amine; AC1MJII5; 5-Bromomethyl-oxazolidin-(2Z)-ylideneamine; SCHEMBL11817450; MolPort-001-940-341; 5-(Bromomethyl)oxazolidine-2-imine; SBB010634; BDBM50138186; AKOS016344418; AKOS000301813; BAS 00615750; 5-(bromomethyl)-1,3-oxazoline-2-ylamine; BB 0261596
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C4H7BrN2O
|
|||
| Canonical SMILES |
C1C(OC(=N1)N)CBr
|
|||
| InChI |
1S/C4H7BrN2O/c5-1-3-2-7-4(6)8-3/h3H,1-2H2,(H2,6,7)
|
|||
| InChIKey |
DCJDVEKKUOXALB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor. Bioorg Med Chem Lett. 2004 Jan 19;14(2):313-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.